XML 22 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments
9 Months Ended
Sep. 30, 2018
Cash and Cash Equivalents [Abstract]  
Financial Instruments
Financial Instruments
Cash, Cash Equivalents and Restricted Cash
The following table summarizes the Company’s cash and cash equivalents and restricted cash (in thousands):
 
 
September 30,
2018
 
December 31,
2017
 
 
Amortized
Cost
 
Estimated
Fair Value
 
Amortized
Cost
 
Estimated
Fair Value
 
 
 
 
 
 
 
 
 
Cash
 
$
84,151

 
$
84,151

 
$
101,356

 
$
101,356

Money market funds
 
360,075

 
360,075

 
79,256

 
79,256

 
 
$
444,226

 
$
444,226

 
$
180,612

 
$
180,612

As reported
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
395,516

 
$
395,516

 
$
103,828

 
$
103,828

Restricted cash
 
48,710

 
48,710

 
76,784

 
76,784

 
 
$
444,226

 
$
444,226

 
$
180,612

 
$
180,612


As of September 30, 2018 and December 31, 2017, the Company had restricted cash of $48.7 million and $76.8 million, respectively, as follows (in thousands):
 
 
September 30,
2018
 
December 31,
2017
 
 
 
 
 
Restricted cash related to PPA Entities
 
$
3,252

 
$
7,969

Restricted cash
 
14,679

 
36,418

Restricted cash, current
 
17,931

 
44,387

Restricted cash related to PPA Entities
 
27,778

 
26,748

Restricted cash
 
3,001

 
5,649

Restricted cash, non-current
 
30,779

 
32,397

Total restricted cash
 
$
48,710

 
$
76,784


Short-Term Investments
As of September 30, 2018 and December 31, 2017, the Company had short-term investments in U.S. Treasury Bills of $4.5 million and $26.8 million, respectively.
Derivative Instruments
The Company has derivative financial instruments related to natural gas forward contracts and interest rate swaps. See Note 7 - Derivative Financial Instruments for a full description of the Company's derivative financial instruments.